Mortality in nondemented subjects with cognitive impairment: The influence of health-related factors

American Journal of Epidemiology

Volumn 150, Issue 10, 1999, Pages 1031-1044

  Frisoni, Giovanni B ^a,b,c   Fratiglioni, Laura ^a   Fastbom, Johan ^a   Viitanen, Matti ^a   Winblad, Bengt ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b IRCCS ISTITUTO CENTRO SAN GIOVANNI DI DIO FATEBENEFRATELLI   (Italy)

^c STOCKHOLM GERONTOLOGY RESEARCH CENTER   (Sweden)

Author keywords

Aged; Apolipoprotiens E; Chronic disease; Cognition; Comorbidity; Dementia; Frail elderly; Health

Indexed keywords

APOLIPOPROTEIN E;

AGED; ARTICLE; COGNITIVE DEFECT; COMORBIDITY; CONTROLLED STUDY; DEMENTIA; DISEASE ASSOCIATION; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MENTAL HEALTH; MORTALITY; NUTRITIONAL STATUS; PROGNOSIS; RISK ASSESSMENT;

EID: 0032753470     PISSN: 00029262     EISSN: None     Source Type: Journal    
DOI: 10.1093/oxfordjournals.aje.a009927     Document Type: Article

References (67)

1. Gill TM, Williams CS, Richardson ED, et al. Impairments in physical performance and cognitive status as predisposing factors for functional dependence among non-disabled older persons. J Gerontol A Biol Sci Med Sci 1996;51:M283-8.
2. Ely M, Melzer D, Opit L, et al. Estimating the numbers and characteristics of elderly people with cognitive disability in local populations. Res Policy Plan 1996;14:13-18.
3. Agüero-Torres H, Fratiglioni H, Guo Z, et al. Mortality from dementia in advanced age. A 5-year follow-up study of incident dementia cases. J Clin Epidemiol 1999;52:737-43.
4. Geldmacher DS, Whitehouse PJ. Evaluation of dementia. N Eng J Med 1996;335:330-6.
5. Mesulam MM. Dementia: its definition, differential diagnosis, and subtypes. JAMA 1985;253:2559-61.
6. Graham JE, Rockwood K, Beattie BL, et al. Prevalence and severity of cognitive impairment with and without dementia in an elderly population. Lancet 1997;349:1793-6.
7. Berr C, Dartigues JF, Alperovitch A. Cognitive performance and three-year mortality in the PAQUID elderly study. Rev Epidemiol Sante Publique 1994;42:277-84.
8. Johansson B, Zarit SH. Early cognitive markers of the incidence of dementia and mortality: a longitudinal population-based study of the oldest old. Int J Geriatr Psychiatry 1997; 12:53-9.
9. Small BJ, Bäckman L. Cognitive correlates of mortality: evidence from a population-based sample of very old adults. Psychol Aging 1997;12:309-13.
10. Ebly EM, Hogan DB, Parhad IM. Cognitive impairment in the nondemented elderly. Results from the Canadian Study of Health and Aging. Arch Neurol 1995;52:612-19.
11. Haan MN, Weldon M. The influence of diabetes, hypertension, and stroke on ethnic differences in physical and cognitive functioning in an ethnically diverse older population. Ann Epidemiol 1996;6:392-8.
12. Vanhanen M, Koivisto K, Karjalainen L, et al. Risk for non-insulin-dependent diabetes in the normoglycaemic elderly is associated with impaired cognitive function. Neuroreport 1997;8:1527-30.
13. Zuccala G, Cattel C, Manes-Gravina E, et al. Left ventricular dysfunction: a clue to cognitive impairment in older patients with heart failure. J Neurol Neurosurg Psychiatry 1997;63: 509-12.
14. Post SG, Whitehouse PJ. Emerging antidementia drugs - a preliminary ethical view. J Am Geriatr Soc 1998;46:784-7.
15. Fratiglioni L, Viitanen M, Bäckman L, et al. Occurrence of dementia in advanced age: the study design of the Kungsholmen Project. Neuroepidemiology 1992;11(suppl 1): 29-36.
16. Folstein M, Folstein S, McHugh P. The Mini Mental State Examination. J Psychiatr Res 1975;12:189-98.
17. Grut M, Fratiglioni L, Viitanen M, et al. Accuracy of the Mini-Mental Status Examination as a screening test for dementia in a Swedish elderly population. Acta Neurol Scand 1993;87: 312-17.
18. American Psychiatric Association. Diagnostic and statistical manual of mental disorders: DSM IIIR. 3rd ed., rev. Washington, DC: American Psychiatric Association, 1987.
19. Fratiglioni L, Grut M, Forsell Y, et al. Prevalence of Alzheimer's disease and other dementias in an elderly urban population: relationship with age, sex, and education. Neurology 1991;41:1886-92.
20. von Strauss E, Fratiglioni L, Jorm AF, et al. Attitudes and participation of the elderly in population surveys: data from a longitudinal study on aging and dementia in Stockholm. J Clin Epidemiol 1996;51:181-7.
21. Hastie T, Tibshirani R. Generalized additive models. London, UK: Chapman & Hall, 1990.
22. MathSoft. S-plus 4: guide to statistics. Seattle, WA: MathSoft, 1997.
23. Crum RM, Anthony JC, Bassett SS, et al. Population-based norms for the Mini-Mental State Examination by age and educational level. JAMA 1993;269:2386-91.
24. Fastbom J, Claesson CB, Cornelius C, et al. The use of medicines with anticholinergic effects in older people: a population study in an urban area of Sweden. J Am Geriatr Soc 1995; 43:1135-40.
25. Nordic Council on Medicines. Guidelines for ATC classification. Oslo: WHO Collaborating Centre for Drug Statistics Methodology, 1990.
26. Basun H, Corder EH, Guo Z, et al. Apolipoprotein E polymorphism and stroke in a population sample aged 75 years or more. Stroke 1996;27:1310-15.
27. World Health Organization. International classification of diseases, injuries, and causes of death. Eighth Revision. Geneva: World Health Organization, 1967.
28. von Korff M, Wagner EH, Saunders K. A chronic disease score from automated pharmacy data. J Clin Epidemiol 1992;45: 197-203.
29. Harris T, Cook EF, Garrison R, et al. Body mass index and mortality among nonsmoking older persons. JAMA 1988;259: 1520-4.
30. Katz S, Downs TD, Cash HR, et al. Progress in development of the index of ADL. Gerontologist 1970;10:20-30.
31. Korn EL, Graubard BI, Midthune D. Time-to-event analysis of longitudinal follow-up of a survey: choice of the time-scale. Am J Epidemiol 1997;145:72-80.
32. Heitjan DF. Annotation: what can be done about missing data? Approaches to imputation. Am J Public Health 1997;87: 48-50.
33. Davignon J, Gregg RE, Sing CF. Apolipoprotein E polymorphism and atherosclerosis. Arteriosclerosis 1988;8:1-21.
34. Eagles JM, Beattie JA, Restall DB, et al. Relation between cognitive impairment and early death in the elderly. BMJ 1990;300:239-40.
35. Liu IY, LaCroix AZ, White LR, et al. Cognitive impairment and mortality: a study of possible confounders. Am J Epidemiol 1990;132:136-43.
36. Perls TT, Morris JN, Ooi WL, et al. The relationship between age, gender and cognitive performance in the very old: the effect of selective survival. J Am Geriatr Soc 1993;41: 1193-201.
37. Salive ME, Satterfield S, Ostfeld AM, et al. Disability and cognitive impairment are risk factors for pneumonia-related mortality in older adults. Public Health Rep 1993;108:314-22.
38. Kelman HR, Thomas C, Kennedy GJ, et al. Cognitive impairment and mortality in older community residents. Am J Public Health 1994;84:1255-60.
39. Swan GE, Carmelli D, LaRue A. Performance on the digit symbol substitution test and 5-year mortality in the Western Collaborative Group Study. Am J Epidemiol 1995;141:32-40.
40. Bruce ML, Hoff RA, Jacobs SC, et al. The effects of cognitive impairment on 9-year mortality in a community sample. J Gerontol B Psychol Sci Soc Sci 1995;50:P289-96.
41. Gale CR, Martyn CN, Cooper C. Cognitive impairment and mortality in a cohort of elderly people. BMJ 1996;312:608-11.
42. Gussekloo J, Westendorp RG, Remarque EJ, et al. Impact of mild cognitive impairment on survival in very elderly people: cohort study. BMJ 1997;315:1053-4.
43. Barrett-Connor E, Stuenkel CA. Questions of life and death in old age. JAMA 1998;279:622-3.
44. Guralnik JM. Assessing the impact of comorbidity in the older population. Ann Epidemiol 1996;6:376-80.
45. Cornoni-Huntley JC, Foley DJ, Guralnik JM. Co-morbidity analysis: a strategy for understanding mortality, disability and use of health care facilities of older people. Int J Epidemiol 1991;20(suppl 1):S8-17.
46. Fried LP, Kronmal RA, Newman AB, et al, for the Cardiovascular Health Study Collaborative Research Group. Risk factors for 5-year mortality in older adults. The Cardiovascular Health Study. JAMA 1998;279:585-92.
47. Staessen J, Bulpitt C, Clement D, et al. Relation between mortality and treated blood pressure in elderly patients with hypertension: report of the European Working Party on High Blood Pressure in the Elderly. BMJ 1989;298:1552-6.
48. Wang HX, Fratiglioni L, Frisoni GB, et al. Smoking and the occurrence of Alzheimer's disease: cross-sectional and longitudinal data in a population-based study. Am J Epidemiol 1999;149:640-4.
49. Guo Z, Fratiglioni L, Winblad B, et al. Blood pressure and performance on the Mini-Mental State Examination in the very old. Cross-sectional and longitudinal data from the Kungsholmen Project. Am J Epidemiol 1997;145:1106-13.
50. Brenner DE, Kukull WA, van Belle G, et al. Relation between cigarette smoking and Alzheimer's disease in a population-based case-control study. Neurology 1993;43:293-300.
51. Farmer ME, White LR, Abbott RD, et al. Blood pressure and cognitive performance. The Framingham Study. Am J Epidemiol 1987;126:1103-14.
52. Christensen H, Mackinnon A. The association between mental, social and physical activity and cognitive performance in young and old subjects. Age Ageing 1993;22:175-82.
53. Louhija J, Miettinen HE, Kontula K, et al. Aging and genetic variation of plasma apolipoproteins. Relative loss of the apolipoprotein 4 phenotype in centenarians. Arterioscler Thrombi 1994;14:1084-9.
54. From the Centers for Disease Control. Prevalence, incidence of diabetes mellitus-United States, 1980-1987. (Editorial). JAMA 1990;264:3126.
55. Reisberg B, Schneider L, Doody R, et al. Clinical global measures of dementia. Position paper from the International Working Group on Harmonization of Dementia Drug Guidelines. Alzheimer Dis Assoc Disord 1997;11(suppl 3): 8-18.
56. Berg S. Aging, behavior and terminal decline. In: Birren JE, Schaie KW, eds. Handbook of the psychology of aging. 34th ed. New York: Academic Press, 1996.
57. Ader R, Cohen N, Felten D. Psychoneuroimmunology: interactions between the nervous system and the immune system. Lancet 1995;345:99-103.
58. Musselman DL, Tomer A, Manatunga AK, et al. Exaggerated platelet reactivity in major depression. Am J Psychiatry 1996; 153:1313-17.
59. Phillips DP, Smith DG. Postponement of death until symbolically meaningful occasions. JAMA 1990;263:1947-51.
60. Frasure-Smith N, Lesperance F, Talajic M. Depression following myocardial infarction. Impact on 6-month survival. JAMA 1993;270:1819-25.
61. Emery VO, Oxman TE. Update on the dementia spectrum of depression. Am J Psychiatry 1992;149:305-17.
62. Forsell Y, Winblad B. Major depression in a population of demented and nondemented older people: prevalence and correlates. J Am Geriatr Soc 1998;46:27-30.
63. Daffner KR, Scinto LF, Weintraub S, et al. Diminished curiosity in patients with probable Alzheimer's disease as measured by exploratory eye movements. Neurology 1992;42:320-8.
64. Oken BS, Kishiyama SS, Kaye JA, et al. Attention deficit in Alzheimer's disease is not simulated by an anticholinergic/ antihistaminergic drug and is distinct from deficits in healthy aging. Neurology 1994;44:657-62.
65. Katzman R, Hill LR, Yu ES, et al. The malignancy of dementia. Predictors of mortality in clinically diagnosed dementia in a population survey of Shanghai, China. Arch Neurol 1994;51: 1220-5.
66. Evans DA, Smith LA, Scherr PA, et al. Risk of death from Alzheimer's disease in a community population of older persons. Am J Epidemiol 1991;134:403-12.
67. Deeg DJ, Hofman A, van Zonneveld RJ. The association between change in cognitive function and longevity in Dutch elderly. Am J Epidemiol 1990;132:973-82.